神经纤维瘤病(非恶性)的临床试验
总计287个结果
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration Program招聘中
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)终止
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
University of UtahUniversity of British Columbia; Children's Hospital Medical Center, Cincinnati; U.S. Army Medical... 和其他合作者终止
-
University of Alabama at Birmingham完全的
-
Ann & Robert H Lurie Children's Hospital of ChicagoNational Institute of Neurological Disorders and Stroke (NINDS); Children's Hospital Medical...招聘中
-
SpringWorks Therapeutics, Inc.主动,不招人
-
AstraZenecaMerck Sharp & Dohme LLC主动,不招人
-
Ann & Robert H Lurie Children's Hospital of Chicago完全的
-
Novartis Pharmaceuticals终止
-
Massachusetts General HospitalJohns Hopkins University主动,不招人
-
Medical University Innsbruck未知
-
University of UtahNational Institute of Neurological Disorders and Stroke (NINDS)完全的
-
National Cancer Institute (NCI)完全的
-
University Hospital, Toulouse完全的
-
AstraZeneca完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.尚未招聘
-
Children's National Research InstituteEmory University; University of Texas Southwestern Medical Center; Arizona State University完全的
-
Shriners Hospitals for ChildrenUniversity of Utah; Thrasher Research Fund完全的
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington University School... 和其他合作者完全的
-
NYU Langone HealthNovartis Pharmaceuticals; The Children's Tumor Foundation完全的
-
AstraZenecaMerck Sharp & Dohme LLC主动,不招人
-
Shriners Hospitals for ChildrenUniversity of Utah完全的
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington University School... 和其他合作者完全的
-
AstraZenecaMerck Sharp & Dohme LLC主动,不招人
-
National Cancer Institute (NCI)主动,不招人神经纤维瘤病 1 (NF1) | 丛状神经纤维瘤 (PN)美国
-
University of Alabama at BirminghamPacific Pediatric Neuro-Oncology Consortium; Array BioPharma主动,不招人
-
NYU Langone Health完全的神经纤维瘤病 1 型和 2 型(NF1 和 NF2)美国